Attovia Therapeutics | $105,000,000 | (May 14, 2024)
Glacis Labs | $2,000,000 | (May 14, 2024)
hexafarms | $1,403,746 | (May 14, 2024)
Valid8 Financial
United States
- Seattle, Washington
- 01/12/2023
- Series A
- $8,500,000
World class financial investigations need to be fast, accurate, and comprehensive. Valid8 extracts and reconciles banking transactions from any PDF statement file in less than 24 hours. Transfers between accounts and legal entities are identified to compress data preparation time and simplify asset discovery and finding fraudulent transfers.
- Industry Financial Services
- Website https://www.valid8financial.com/
- LinkedIn https://www.linkedin.com/company/valid8-financial/about/
Related People
Chris McCallCo Founder
United States -
Boulder, Colorado
World class financial investigations need to be fast, accurate, and comprehensive. Valid8 extracts and reconciles banking transactions from any PDF statement file in less than 24 hours. Transfers between accounts and legal entities are identified to compress data preparation time and simplify asset discovery, finding preference payments and fraudulent transfers. Interactive data visualizations help professionals develop compelling case narratives and simplify story telling.
CereVasc | $70,000,000 | (May 14, 2024)
GigPig | $1,631,441 | (May 14, 2024)
Active Surfaces | $5,600,000 | (May 14, 2024)
May Health | $25,000,000 | (May 14, 2024)
ByHeart | $95,000,000 | (May 14, 2024)
tiney | $9,034,812 | (May 14, 2024)
Hexis | $2,009,680 | (May 14, 2024)
Nivoda | $30,000,000 | (May 14, 2024)
Switchboard Health | $6,500,000 | (May 14, 2024)